BACKGROUND: Studies of the associations of circulating total 25-hydroxyvitamin D (25(OH)D) with cardiovascular disease risk factors in adults have reported inconsistent findings. We aimed to compare prospective associations of two analogues of childhood 25(OH)D (25(OH)D2 and 25(OH)D3) with cardiovascular risk factors measured in adolescence. METHODS AND RESULTS: We examined associations of childhood (ages 7-12 years) 25(OH)D2 and 25-25(OH)D3 with a range of cardiovascular risk factors (blood pressure, fasting lipids, glucose, insulin and C-reactive protein (CRP)) determined in adolescence (mean age 15.4 years). Data were from 2470 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective population-based cohort. After adjustments for age, gender, socioeconomic position and BMI, there were no associations of 25(OH)D2 with cardiovascular risk factors. There was a positive association of season-adjusted (and unadjusted) 25(OH)D3 with high-density lipoprotein cholesterol (HDL-C) (mean change per doubling of 25(OH)D3: 0.03 mmol/l; 95% confidence interval (CI): 0.001 to 0.05, p = 0.02) and an inverse association with fasting insulin (relative difference of -4.59% per doubling; 95% CI: -8.37 to -0.59, p = 0.03). Participants with total 25(OH)D concentration <50 nmol/l had 0.04 mmol/l lower HDL-C (95% CI: -0.07 to -0.01) and 5.54% higher fasting insulin (95% CI: 0.82 to 10.47) compared with participants with total 25(OH)D ≥72 nmol/l. CONCLUSIONS: In the first prospective study of children/adolescents, we have shown that higher 25(OH)D3 concentrations in childhood are associated with higher levels of HDL-C and lower fasting insulin in adolescence.
BACKGROUND: Studies of the associations of circulating total 25-hydroxyvitamin D (25(OH)D) with cardiovascular disease risk factors in adults have reported inconsistent findings. We aimed to compare prospective associations of two analogues of childhood 25(OH)D (25(OH)D2 and 25(OH)D3) with cardiovascular risk factors measured in adolescence. METHODS AND RESULTS: We examined associations of childhood (ages 7-12 years) 25(OH)D2 and 25-25(OH)D3 with a range of cardiovascular risk factors (blood pressure, fasting lipids, glucose, insulin and C-reactive protein (CRP)) determined in adolescence (mean age 15.4 years). Data were from 2470 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective population-based cohort. After adjustments for age, gender, socioeconomic position and BMI, there were no associations of 25(OH)D2 with cardiovascular risk factors. There was a positive association of season-adjusted (and unadjusted) 25(OH)D3 with high-density lipoprotein cholesterol (HDL-C) (mean change per doubling of 25(OH)D3: 0.03 mmol/l; 95% confidence interval (CI): 0.001 to 0.05, p = 0.02) and an inverse association with fasting insulin (relative difference of -4.59% per doubling; 95% CI: -8.37 to -0.59, p = 0.03). Participants with total 25(OH)D concentration <50 nmol/l had 0.04 mmol/l lower HDL-C (95% CI: -0.07 to -0.01) and 5.54% higher fasting insulin (95% CI: 0.82 to 10.47) compared with participants with total 25(OH)D ≥72 nmol/l. CONCLUSIONS: In the first prospective study of children/adolescents, we have shown that higher 25(OH)D3 concentrations in childhood are associated with higher levels of HDL-C and lower fasting insulin in adolescence.
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Thomas W Dunlop; Sami Väisänen; Christian Frank; Ferdinand Molnár; Lasse Sinkkonen; Carsten Carlberg Journal: J Mol Biol Date: 2005-04-07 Impact factor: 5.469
Authors: Dylan M Williams; Abigail Fraser; Adrian Sayers; William D Fraser; Aroon Hingorani; John Deanfield; George Davey Smith; Naveed Sattar; Debbie A Lawlor Journal: J Clin Endocrinol Metab Date: 2012-02-16 Impact factor: 5.958
Authors: Jennifer M Sacheck; Qiushi Huang; Maria I Van Rompay; Virginia R Chomitz; Christina D Economos; Misha Eliasziw; Catherine M Gordon; Elizabeth Goodman Journal: Am J Clin Nutr Date: 2022-01-11 Impact factor: 7.045
Authors: Maria I Van Rompay; Nicola M McKeown; Elizabeth Goodman; Misha Eliasziw; Virginia R Chomitz; Catherine M Gordon; Christina D Economos; Jennifer M Sacheck Journal: J Nutr Date: 2015-09-02 Impact factor: 4.798
Authors: P S Gibson; A Quaglia; A Dhawan; H Wu; S Lanham-New; K H Hart; E Fitzpatrick; J B Moore Journal: Pediatr Obes Date: 2018-05-14 Impact factor: 4.000
Authors: Aimée E van Dijk; Karen Dawe; John Deanfield; Karien Stronks; Reinoud J B J Gemke; Tanja G M Vrijkotte; Debbie A Lawlor Journal: Eur J Prev Cardiol Date: 2013-04-04 Impact factor: 7.804